Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]Florbetaben PET for Amyloidosis in Multiple Myeloma
NCT03779815Phase 2Completed
- Sponsor
- Ulsan University Hospital
- Start
- Aug 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of flutemetamol in amyloidosis, sponsored by Ulsan University Hospital. Started Aug 2018; status: completed.
02
Drugs
flutemetamol
03
Conditions
amyloidosis
Beyond the preview
Go deeper on NCT03779815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03779815.